2027 International Standard for Therapeutic Use Exemptions (ISTUE) - In Force on 1 January 2027
The current edition of the International Standard for Therapeutic Use Exemptions, in force from 1 January 2027; concurrent with the 2027 edition of the Code.
| In force from | 1 January 2027 |
| Published by | World Anti-Doping Agency — 2027 edition |
| Structure | International Standard for Therapeutic Use Exemptions, 2027 edition |
| Status | Current version — in force from 1 January 2027 |
What is the International Standard for Therapeutic Use Exemptions?
The International Standard for Therapeutic Use Exemptions (ISTUE) is one of the mandatory International Standards of the world anti-doping system. The International Standards set out the technical detail of implementing the Code, and compliance with them is compulsory for all Signatories to the Code. This Standard determines the conditions under which, and the route by which, an athlete who is compelled by illness to use a prohibited substance or method obtains a therapeutic use exemption, who decides the application, and in which cases the decision is open to review and appeal.
About the January 2027 editionChanges from 2023
Most important changes from the previous edition
- Alignment with the 2027 CodeThis edition enters into force at the same time as the 2027 edition of the Code and has been aligned with its changes — including the expanded status of the Protected Person.
Who this document matters to
The most frequently used Standard for team doctors and athletes. The four conditions for granting an exemption, the deadline for submitting an application, the possibility of applying with retroactive effect, and the body that decides applications and appeals are all set out in this text; and in doping cases, the existence or absence of a valid exemption is the first thing examined.
Each case is governed by the version of this Standard that was in force at the time of the relevant event; for that reason, earlier versions are kept available on this page. The official text is published in English and French and, in the event of divergence, the English text prevails.